https://zevaskyn.com/
Home | ZEVASKYN® (prademagene zamikeracel) Patient
May 20, 2026 - Discover ZEVASKYN® (prademagene zamikeracel), durable wound healing for RDEB wounds—helping throughout all the different stages of wound healing
patient
https://zevaskynhcp.com/
ZEVASKYN® (prademagene zamikeracel) | RDEB Treatment
Jun 23, 2026 - ZEVASKYN® (prademagene zamikeracel) is the first and only autologous cell sheet-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB).
treatment
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f8782480-8782-4748-9764-b9ed60979d47
DailyMed - ZEVASKYN- prademagene zamikeracel cellular sheet
dailymedzevaskyncellularsheet